Overview: MTB Rifampicin Resistance Genexpert TestIntroduction: The MTB Rifampicin Resistance Genexpert Test detects Mycobacterium tuberculosis and rifampicin resistance, confirming tuberculosis causing cough or weight loss. Following 2023 WHO guidelines, it uses PCR for high specificity, aiding in infectious disease screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in bacteriology for patients with suspected tuberculosis.
Other Names: Genexpert MTB Assay, TB Rifampicin Resistance Test.
FDA Status: FDA-cleared diagnostic test, meeting bacteriology standards for diagnostic accuracy.
Historical Milestone: Genexpert testing began in the 2000s with tuberculosis research. PCR-based assays emerged in the 2010s, improving accuracy for resistance detection.
Purpose: Diagnoses tuberculosis, detects rifampicin resistance, and guides treatment in patients with cough or weight loss.
Test Parameters: 1. MTB and Rifampicin Resistance
Pretest Condition: No fasting required. Collect sputum, BAL, tissue, or body fluid at any time. Report symptoms like cough or weight loss, and list medications.
Specimen: 5-10 mL sputum, bronchoalveolar lavage, body fluid (sterile container), or 0.5-2 cma³ tissue (sterile container). Transport in a biohazard bag within 2 hours.
Sample Stability at Room Temperature: 2 hours
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not frozen
Medical History: Document cough, weight loss, or history of tuberculosis. Include current medications, especially antitubercular drugs.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for antitubercular therapy.
Procedural Considerations: Uses PCR to detect MTB and rifampicin resistance genes. Results are available in 3-5 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Contamination or low bacterial load can affect results. Early infections may yield false negatives.
Clinical Significance: Positive MTB and rifampicin resistance confirm tuberculosis and guide treatment. Negative results may require further testing.
Specialist Consultation: Consult an infectious disease specialist or pulmonologist for result interpretation.
Additional Supporting Tests: AFB smear, TB culture, or chest X-ray to confirm tuberculosis.
Test Limitations: False negatives may occur with low bacterial load. Results require clinical correlation.
References: WHO TB Guidelines, 2023; Clinical Infectious Diseases, Dheda K, 2022.
